Peter Hulick to Patient Selection
This is a "connection" page, showing publications Peter Hulick has written about Patient Selection.
Connection Strength
0.022
-
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study. Eur Urol. 2014 Sep; 66(3):489-99.
Score: 0.022